Company: BDRX
Filing Date: 2025-04-11
Form Type: 20-F
Source: 0001214659-25-005742
Chunk: 26

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-11
Form: 20-F
Item: Item 16A
Chunk 26
---

ITEM 16A.   AUDIT COMMITTEE FINANCIAL EXPERT.
---------------------------------------------
 
The Audit Committee consists of three members: Simon Turton (Chairman), Stephen Parker and Ann Merchant. The Board of Directors has determined that Messrs. Turton and Parker and Ms. Merchant are independent under Rule 10A-3 of the Exchange Act and the applicable rules of NASDAQ and that Dr. Turton qualifies as an “audit committee financial expert” as defined under in Item 16A of Form 20-F.